Fedley Healthcare: India's Trusted Ofloxacin 50 mg Suspension With Monocarton

DCGI Approved WHO-GMP
OFLORIV by Fedley Healthcare
Syrups

OFLORIV

Product Composition

Ofloxacin 50 mg Suspension With Monocarton

Packing
60ML
Release Type
PET BOTTLE
DCGI Approved
WHO-GMP Certified
PET BOTTLE
Pan India Delivery
Product Price
MRP (Inclusive of all taxes)
₹44.06
Get Franchise QuoteWhatsApp Us
ISO 9001:2015
1000+ Products
29+ States
Share:

Uses of OFLORIV

Ofloxacin 50 mg Suspension With Monocarton is prescribed for various conditions related to inflammation, pain, and joint disorders.

Quality-Driven Manufacturing Behind OFLORIV

1000+
DCGI Approved Products
12+
Years of Experience
2000+
Franchise Partners
29+
States Covered

PCD Pharma Franchise for Ofloxacin 50 mg Suspension With Monocarton — Available Across India

Fedley Healthcare provides exclusive monopoly-based PCD franchise rights for OFLORIV in all major states and union territories across India.

PunjabHaryanaRajasthanUttar PradeshMadhya PradeshGujaratMaharashtraKarnatakaTamil NaduKeralaAndhra PradeshTelanganaWest BengalBiharJharkhandOdishaChhattisgarhAssamMeghalayaTripuraManipurNagalandMizoramArunachal PradeshSikkimUttarakhandHimachal PradeshGoaJammu & KashmirDelhi NCRChandigarhPuducherry

Exclusive monopoly rights available — contact us to check availability in your state & district.

Why Fedley Healthcare vs Other Manufacturers?

See how we compare with typical pharma manufacturers in India.

Factor
Fedley Healthcare
Others
WHO-GMP Certification
Certified
Often Not
DCGI Approved Products
1000+
Limited
Monopoly Rights
Exclusive Territory
Shared
Marketing Support
Visual Aids, LBLs, Gifts
Minimal / Paid
Product Quality
SR Technology
Standard
Delivery
Pan India, On-Time
Delayed
MOQ (Min Order)
Flexible & Low
High Minimum
Profit Margins
Attractive (High ROI)
Thin Margins
Ethical Promotion
100% Ethical
Questionable
Franchise Support
Dedicated Manager
No Post-Sale Support
WHO-GMP Certification
Fedley
Certified
Others
Often Not
DCGI Approved Products
Fedley
1000+
Others
Limited
Monopoly Rights
Fedley
Exclusive Territory
Others
Shared
Marketing Support
Fedley
Visual Aids, LBLs, Gifts
Others
Minimal / Paid
Product Quality
Fedley
SR Technology
Others
Standard
Delivery
Fedley
Pan India, On-Time
Others
Delayed
MOQ (Min Order)
Fedley
Flexible & Low
Others
High Minimum
Profit Margins
Fedley
Attractive (High ROI)
Others
Thin Margins
Ethical Promotion
Fedley
100% Ethical
Others
Questionable
Franchise Support
Fedley
Dedicated Manager
Others
No Post-Sale Support

Start Your Pharma Business with OFLORIV — Get Exclusive Franchise Rights in Your State Today

Join 2000+ successful franchise partners across India. Low investment, high returns, complete marketing support.

Get Franchise Quote Now

Get Franchise Quote for OFLORIV

Interested in Ofloxacin 50 mg Suspension With Monocarton for your pharma franchise business? Fill the form and our team will get back to you with pricing, MOQ, and exclusive territory details.

  • Exclusive Monopoly Rights in Your Territory
  • Attractive Profit Margins & Low Investment
  • Timely Product Delivery Across India
  • Free Promotional Support (Visual Aids, LBLs, Gifts)

Send Enquiry

Fill in your details and we'll contact you shortly.

Product: OFLORIV | Ofloxacin 50 mg Suspension With Monocarton

Or call us: +91-9855986633 | +91-9317692852

Customer Reviews

4.8based on 147 ratings

Great experience with OFLORIV. The Ofloxacin 50 mg Suspension With Monocarton formulation works as expected. WHO-GMP certified quality gives confidence in recommending to patients.

DS

Dr. Sunita Rao

Verified Purchase

15 Mar 2026

OFLORIV is one of the best formulations I have come across. The Ofloxacin 50 mg Suspension With Monocarton blend works effectively and patients have reported noticeable improvement.

MG

Mohit Gupta

Verified Purchase

20 Oct 2025

OFLORIV stands out for its quality manufacturing. The Ofloxacin 50 mg Suspension With Monocarton composition is effective and I have seen good patient compliance with this formulation.

AS

Amit Saxena

Verified Purchase

5 Jan 2026